alexa Value of 18F-FDG-PET/CT Initial Staging in No Metastasic Breast Cancer with Poor Prognostic Factors

OMICS Journal of Radiology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Value of 18F-FDG-PET/CT Initial Staging in No Metastasic Breast Cancer with Poor Prognostic Factors

Alberto Martinez Lorca1*, Alejandro Gallego2, Cristina Escabias1 and Pilar Zamora2
1Nuclear Medicine Department, Hospital Universitario La Paz, Nuclear Medicine, Spain
2Medical Oncology Department, Universitary Hospital La Paz, Madrid, Spain
Corresponding Author : Alberto Martinez Lorca
Department of Nuclear Medicine
Hospital Universitario La Paz
Madrid-28046, Spain
Tel: +0034679732928
E-mail: [email protected]
Received: July 3, 2015 Accepted: August 06, 2015 Published: August 10, 2015
Citation: Lorca AM, Gallego A, Escabias C, Zamora P (2015) Value of 18F-FDG-PET/CT Initial Staging in No Metastasic Breast Cancer with Poor Prognostic Factors. OMICS J Radiol 4:201. doi:10.4172/2167-7964.1000201
Copyright: © 2015 Lorca AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Purpose: This study analysed retrospectevely the impact of 18F-FDG-PET/CT initial staging, in women with poor prognosis factors breast cancer, in our usual practice.

Methods: From January 2009 to December 2012, initial breast cancer underwent PET/CT in 298 women with one of these poor prognosis factors: Her-2+ or triple negative phenotype, Ki 67 ≥ 14%, tumoral size and/or positive axilary lymph nodes. Only 254 patients diagnosed with mammography, ultrasonography, MRI, and bone scintigraphy accomplished inclusion criteria.

Results: 18F-FDG-PET/CT changed 13.4% to IV clinical stage, detected metastatic disease in 3.3% of patients with stage I, 13% with stage II and 17.4% with stage III. Statistical significance was found between the PET/CT metastatic disease findings and patients with stage IIB and III(A-C)(OR:3.04;IC95%:1.2-7.2;p=0.009). PET/CT also revealed N3 disease in 7.9%. According to the location, visceral affectation was found in 4.7% of the patients, metastatic lymph nodes in 3.2% and secondary bone disease in 8.7%. Her-2 negative and hormonal positive receptors group submitted a higher incidence of distant metastases, 15.5%. The more visceral and lymph node disease (N3 and distant-M1) was found in the triple negative group. Metastatic disease was observed in 28.6% of the patients above 70 years, a higher incidence than those patients with lower age (OR: 3.7; IC95%: 1.7 - 8; p = 0.01).

Conclusion: 18F-FDG-PET/CT showed to be useful in the metastatic disease detection from IIB stage patients in initial poor prognosis breast cancer patients. The incidence of distance affectation was higher in patients above 70 years and in the Her-2 negative and hormonal positive receptor group.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version